Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tang Capital Partners
Biotech
Kevin Tang uses control of Aurinia to finally take over Kezar
Aurinia, which named Kevin Tang as its new CEO last week, is acquiring Kezar after the latter company received promising feedback from the FDA.
Will Maddox
Mar 30, 2026 10:53am
iTeos, reeling from TIGIT fail, is latest prize for Concentra
Jul 21, 2025 9:36am
Concentra extends biotech shopping spree by collecting Cargo
Jul 8, 2025 9:28am
Concentra strikes again, circling up IGM Biosciences
Jul 1, 2025 9:58am
Embattled Elevation is latest biotech to accept Concentra buyout
Jun 9, 2025 10:25am
Concentra swoops in to purchase struggling Kronos
May 1, 2025 3:07pm
